Latest News

Ur-Energy (TSX:URE) is forecast to grow revenue at an impressive 34% annually, far outpacing the Canadian market’s 5.1% yearly growth rate. Despite this top-line momentum, the company remains unprofitable, with annual losses deepening by 32.5% over the past five years and no improvement in net profit margins. Investors weighing these results will note that while strong revenue growth is a clear highlight, persistent losses continue to overshadow earnings quality. See our full analysis for...

Axcelis Technologies (ACLS) posted a net profit margin of 15.9%, down from 20.6% a year ago, as recent earnings growth turned negative. Looking ahead, analysts forecast earnings to decline by 7.3% annually over the next three years, with revenue growth expected to slow to 1.1% per year compared to a much faster 10.5% rate for the broader US market. Despite slowing fundamentals, the stock trades at a favorable 18.4x price-to-earnings ratio, which is well below its semiconductor peers, and sits...

Wondering if Bavarian Nordic is a hidden gem or simply riding the latest biotech wave? Let's dig in and see if the stock is living up to its reputation. Bavarian Nordic shares have seen a solid 18.2% jump year-to-date and are up 13.6% over the past year, but there was a slight dip of 0.6% just last week. Recent headlines highlight the company's expanding role in vaccine development, with positive investor sentiment driven by new partnerships and regulatory milestones. These developments have...

Novanta (NOVT) posted a 7.1% annual EPS growth rate over the past five years, but in the most recent year, earnings declined and net profit margins narrowed to 5.5% from 6.5% previously. The bottom line was further impacted by a one-time, $26 million loss, resulting in another layer of pressure on last year’s results. Looking forward, consensus is calling for profits to rebound sharply at 51.5% per year over the next three years, far outpacing the broader US market's 16% annual rate. However,...

Hillman Solutions (HLMN) reported net profit margins of 2.4%, up from last year’s 0.6%, reflecting a notable improvement in profitability. The company delivered a profit growth of 346.7% over the past year, significantly outpacing its five-year average of 57.2% per year. It has now maintained profitable results for several consecutive years. With forecasts pointing to annual earnings growth of 30.3%, investors are weighing the potential for continued momentum against persistent concerns about...

UFP Technologies (UFPT) reported net profit margins of 11.2%, down from 11.7% a year ago, with recent annual earnings growth of 23.8% underperforming its five-year average of 31.6%. Looking ahead, earnings are forecast to rise at 14.33% per year and revenue growth is expected at 5.6% annually, which trails the broader US market’s 10.5% projected pace. While the company's Price-to-Earnings Ratio of 25.6x sits below the US Medical Equipment industry average but above its peer group, shares are...

Wondering if Kennedy-Wilson Holdings is now a value play or if there is more trouble ahead? Let’s dive in and see whether curiosity is rewarded. The stock has tumbled in 2024, dropping 24.7% year-to-date and losing over 28% across the last twelve months as investor sentiment has shifted quickly. Recent headlines have centered on industry-wide volatility in real estate, with rising interest rates and macro uncertainty putting pressure on REITs and property holding firms like Kennedy-Wilson...

Wondering if NPK International is actually a bargain or just riding market hype? You’re not alone, and we’re about to dig into the numbers together. The stock has delivered an impressive 63.9% gain so far this year, with a substantial 80.9% return over the past 12 months. However, the last week saw a slight dip of 4.7%. Just last month, NPK International made headlines by announcing a strategic partnership aimed at expanding into new international markets. Many observers believe this move is...

Wondering if Viridian Therapeutics is truly a bargain or simply treading water? Here is a closer look at what makes this stock potentially interesting for value-minded investors. The share price climbed 8.3% in the past month but is still down 7.1% over the last year. This may suggest shifting investor sentiment and possible untapped growth. Markets have responded dynamically to the company’s recent announcement of promising results from its pipeline treatments for rare diseases. These...

Most readers would already know that Persimmon's (LON:PSN) stock increased by 4.4% over the past three months. However...

In the last year, many NVR, Inc. ( NYSE:NVR ) insiders sold a substantial stake in the company which may have sparked...

The UK market has faced challenges recently, with the FTSE 100 index closing lower amid concerns over weak trade data from China, highlighting global economic uncertainties. Despite these broader market fluctuations, penny stocks remain an intriguing area for investors seeking affordability and potential growth. Though the term "penny stocks" might seem outdated, these smaller or newer companies can offer unique opportunities when backed by strong financial fundamentals.

Key Insights Sportsman's Warehouse Holdings' estimated fair value is US$2.39 based on 2 Stage Free Cash Flow to Equity...

While Birkenstock Holding plc ( NYSE:BIRK ) might not have the largest market cap around , it saw significant share...

Despite an already strong run, Clover Health Investments, Corp. ( NASDAQ:CLOV ) shares have been powering on, with a...

Biodesix, Inc. ( NASDAQ:BDSX ) just released its latest quarterly results and things are looking bullish. Revenues and...

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...

Diamondback Energy (FANG) reported a net profit margin of 28.2%, down from 35% a year ago, while earnings grew 30.4% over the past year. This growth rate is slower than its five-year average growth of 42.3%. Revenue is forecast to rise just 1.6% per year and earnings growth is expected to slow further to 0.2% annually, both trailing the broader US market. Despite tightening margins and slower growth projections, FANG trades at a 9.7x P/E, well below both its industry average of 12.7x and its...

goeasy Ltd.'s ( TSE:GSY ) price-to-earnings (or "P/E") ratio of 9.4x might make it look like a buy right now compared...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Shareholders appeared unconcerned with Grupo Bimbo, S.A.B. de C.V.'s ( BMV:BIMBOA ) lackluster earnings report last...

Key Insights Given the large stake in the stock by institutions, ZipRecruiter's stock price might be vulnerable to...

The stock was sluggish on the back of NMDC Energy - P.J.S.C.'s ( ADX:NMDCENR ) recent earnings report. Along with the...

Diversified Healthcare Trust (DHC) remains unprofitable, with losses escalating at a rate of 28.2% per year over the last five years. Revenue growth is expected to average just 2.1% per year, falling well below the US market average of 10.5%. Profitability is not anticipated in the near future. For investors, this challenging profit outlook comes with a potential reward in the form of DHC's notably low Price-to-Sales Ratio, which is substantially under both industry and peer averages...